TXN

Texas Instruments

$304.36

-8.40%
Jun 23, 2026
Bobby Quantitative Model
Texas Instruments Incorporated is a global semiconductor company that designs and manufactures analog integrated circuits and embedded processors, generating over 95% of its revenue from these chips. It is the world's largest maker of analog chips, a market leader in a stable and essential segment of the electronics supply chain, and also holds a leading position in processors and microcontrollers. The current investor narrative is dominated by a powerful cyclical recovery, with recent explosive earnings and guidance signaling the end of a semiconductor down-cycle and the start of a new growth phase, heavily fueled by surging demand from AI infrastructure and data center construction.

People also watch

Nvidia

Nvidia

NVDA

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis
Intel

Intel

INTC

Analysis

BobbyInvestment Opinion: Should I buy TXN Today?

Rating & Thesis: Hold. TXN is a high-quality company at a premium price; the cyclical recovery thesis is compelling, but the risk/reward is balanced after a 62.77% annual surge, recommending patience for a better entry point. This aligns with a mixed analyst consensus that includes several Neutral/Hold ratings alongside an implied average target price of ~$416.70.

Supporting Evidence: The Hold rating is supported by four key data points. First, valuation is stretched at a forward P/E of 34.27x, a ~40-70% premium to typical semiconductor peers. Second, while growth has inflected positively (10.38% YoY revenue growth), it must accelerate further to justify the multiple. Third, profitability remains a strength with TTM gross margins of 57.02% and ROE of 30.73%. Fourth, the implied 29.1% upside to the analyst target is attractive but is counterbalanced by the stock trading at 95% of its 52-week range, indicating limited near-term margin of safety.

Risks & Conditions: The two biggest risks are valuation compression and a faltering cyclical recovery. This Hold rating would upgrade to a Buy if the forward P/E compresses meaningfully below 30x (offering a better risk/reward) or if revenue growth accelerates consecutively above 15% YoY, confirming the supercycle. It would downgrade to a Sell if quarterly revenue growth decelerates back into negative territory or if gross margins fall sustainably below 55%. Relative to its own history and sector peers, the stock is overvalued, pricing in near-perfect execution of the current growth narrative.

Sign up to view all

TXN 12-Month Price Forecast

The assessment is neutral based on a clash between high-quality fundamentals and excessive optimism priced into the stock. The cyclical recovery is real and TXN is a prime beneficiary, but the 62.77% annual rally has left the stock vulnerable. The base case of consolidation is most likely, offering limited near-term upside to the ~$416 target without a material improvement in growth or margin outlook. The stance would upgrade to bullish on a meaningful pullback (10-15%) that improves the risk/reward, or if consecutive quarters show revenue growth accelerating beyond 15% YoY. It would turn bearish if the next earnings report shows any deceleration in growth or margin pressure, likely triggering the feared multiple compression.

Historical Price
Current Price $304.36
Average Target $397
High Target $464
Low Target $300

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Texas Instruments's 12-month outlook, with a consensus price target around $395.67 and implied upside of +30.0% versus the current price.

Average Target

$395.67

9 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

9

covering this stock

Price Range

$243 - $396

Analyst target range

Buy
2 (22%)
Hold
4 (44%)
Sell
3 (33%)

Analyst coverage is robust with 16 firms providing estimates, indicating strong institutional interest. The consensus sentiment appears mixed but leans cautiously optimistic, as evidenced by recent actions including a Buy from Rosenblatt and UBS, but also an Underperform from Mizuho and Neutral/Hold ratings from several others. The average target price is implied by the estimated EPS and forward P/E: using the average estimated EPS of $12.16 and the forward P/E of 34.27x yields a consensus price target of approximately $416.70, implying a substantial 29.1% upside from the current price of $322.86. The target range, derived from estimated EPS, spans from a low of $11.04 to a high of $13.53. Applying the forward P/E multiple suggests a price range from approximately $378 to $464. The high target likely assumes successful execution on the growth supercycle thesis, multiple expansion, and sustained margin strength. The low target likely factors in potential cyclical headwinds, competitive pressures, or a slower-than-expected recovery. The wide dispersion between targets, coupled with the mix of recent rating actions (e.g., BofA's upgrade from Underperform to Neutral), signals significant uncertainty and debate among analysts regarding the sustainability of the current rally and the appropriate valuation for this cyclical leader.

Drowning in data?

Find the real signal!

Bulls vs Bears: TXN Investment Factors

The bull case, centered on a powerful cyclical recovery, superior fundamentals, and dominant market position, currently holds stronger evidence given the concrete inflection in revenue growth (10.38% YoY), explosive stock momentum, and substantial implied analyst upside (29.1%). However, the bear case presents a formidable counter-argument rooted in extreme valuation risk, with the stock trading at a forward P/E of 34.27x, a significant premium to its sector and near the top of its historical range. The single most important tension in the investment debate is whether TXN's explosive growth and margin profile can justify and sustain its current premium valuation through the entire cycle, or if the market has already priced in perfection, setting the stage for painful multiple compression at the first sign of cyclical weakness or execution misstep.

Bullish

  • Explosive Cyclical Recovery Underway: Q4 2025 revenue grew 10.38% YoY to $4.42B, marking a clear inflection from sequential declines earlier in the year. This signals the end of the semiconductor down-cycle and the start of a new growth phase, heavily fueled by AI and data center demand, as highlighted by recent news of an 18% stock surge on a 90% spike in data center demand.
  • The company maintains industry-leading gross margins of 57.02% (TTM) and a robust net margin of 26.29% in Q4. This superior profitability funds a fortress balance sheet, with TTM free cash flow of $2.60 billion enabling aggressive shareholder returns, including $1.29B in dividends and $403M in buybacks in Q4 alone.
  • Dominant Market Position in Stable Segment: As the world's largest maker of analog chips, generating over 95% of revenue from analog ICs and embedded processors, TXN holds a leadership position in a stable and essential segment of the electronics supply chain. This provides a defensive quality and pricing power within the cyclical semiconductor sector.
  • Strong Technical Momentum and Relative Strength: The stock has gained 62.77% over the past year and 72.48% over the past three months, far outpacing the S&P 500's gains of 24.99% and 15.14%, respectively. Trading at 95% of its 52-week range ($152.73-$331.51) near the high of $331.51 confirms powerful bullish momentum and investor conviction in the recovery thesis.

Bearish

  • Stretched Valuation Leaves No Room for Error: TXN trades at a significant premium to sector averages with a forward P/E of 34.27x and a trailing P/E of 31.53x, well above typical semiconductor multiples in the low-to-mid 20s. Its Price/Sales of 8.92x and EV/EBITDA of 20.59x are also elevated, pricing in perfect execution of the growth supercycle.
  • Vulnerable to Cyclical Slowdown and Multiple Compression: As a cyclical stock with a beta of 1.31, TXN is 31% more volatile than the market. Any disappointment in the pace of the industrial/automotive recovery or a broader sector rotation away from stretched valuations, as noted in recent news questioning chip stock overvaluation, could trigger a sharp multiple contraction and price correction.
  • Recent Parabolic Move Increases Near-Term Pullback Risk: The stock has surged 83.14% over six months and is trading just 2.6% below its 52-week high of $331.51. This parabolic move, coupled with a high beta, leaves the stock technically overextended and vulnerable to a sharp pullback, as evidenced by a historical max drawdown of -30.7%.
  • Mixed Analyst Sentiment Signals Uncertainty: While the average target implies upside, analyst actions reveal significant debate, including an Underperform from Mizuho and several Neutral/Hold ratings alongside recent Buys. The wide target range derived from EPS estimates ($378 to $464) reflects uncertainty about the sustainability of the rally.

TXN Technical Analysis

The stock is in a powerful, sustained uptrend, evidenced by a staggering 62.77% gain over the past year. As of the latest close of $322.86, the price is trading near the top of its 52-week range, approximately 95% of the way from its low of $152.73 to its high of $331.51, indicating strong momentum but also potential overextension. This positioning near all-time highs reflects immense bullish sentiment but leaves the stock vulnerable to a sharp pullback if growth expectations falter. Recent momentum is exceptionally strong and accelerating relative to the broader market. The stock has surged 72.48% over the past three months and 6.80% over the past month, far outpacing the S&P 500's gains of 15.14% and 0.74%, respectively, as shown by relative strength figures of 57.34 and 6.06. This divergence from the market's more modest gains highlights TXN's role as a high-beta, cyclical leader in the current rally, with no signs of short-term trend reversal. Key technical levels are the 52-week high of $331.51 as immediate resistance and the 52-week low of $152.73 as distant support. A decisive breakout above $331.51 would signal a continuation of the bullish supercycle, while a failure could lead to consolidation. The stock's beta of 1.31 confirms it is approximately 31% more volatile than the market, a critical factor for risk management given its recent parabolic move of 83.14% over six months. Investors must size positions accordingly to account for this elevated volatility.

Beta

1.31

1.31x market volatility

Max Drawdown

-30.7%

Largest decline past year

52-Week Range

$153-$334

Price range past year

Annual Return

+51.1%

Cumulative gain past year

PeriodTXN ReturnS&P 500
1m-1.6%-1.6%
3m+54.7%+11.7%
6m+71.8%+6.3%
1y+51.1%+22.2%
ytd+71.5%+7.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TXN Fundamental Analysis

Revenue growth has reaccelerated sharply, marking a clear cyclical inflection. Q4 2025 revenue was $4.42 billion, representing a 10.38% year-over-year increase, a significant improvement from the sequential declines seen in prior quarters of 2025 (Q3: $4.74B, Q2: $4.45B, Q1: $4.07B). The Analog segment, at $3.17 billion, remains the dominant growth driver, comprising the vast majority of sales. This trajectory implies the company is successfully capitalizing on the rebound in industrial and automotive demand, underpinning the investment case for a multi-year recovery. The company is highly profitable with robust and expanding margins. Q4 2025 net income was $1.16 billion, yielding a net margin of 26.29%. The gross margin for the quarter was a healthy 55.89%, and the trailing-twelve-month gross margin stands at 57.02%. While the Q4 gross margin dipped slightly from Q3's 57.42%, the overall profitability profile remains superior for the semiconductor industry, supported by a fab-lite manufacturing strategy and a focus on high-margin analog products. The balance sheet is fortress-like, providing ample financial flexibility. The company boasts a strong current ratio of 4.35 and a debt-to-equity ratio of 0.95, indicating manageable leverage. Most importantly, it generates substantial cash, with TTM free cash flow of $2.60 billion and a return on equity of 30.73%. This powerful cash generation, evidenced by an operating cash flow of $2.25 billion in Q4 alone, funds the company's generous capital returns—$1.29 billion in dividends and $403 million in buybacks that quarter—while supporting internal growth investments without reliance on external financing.

Quarterly Revenue

$4.4B

2025-12

Revenue YoY Growth

+0.10%

YoY Comparison

Gross Margin

+0.55%

Latest Quarter

Free Cash Flow

$2.6B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Analog
Embedded Processing

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TXN Overvalued?

Given a positive net income of $1.16 billion, the primary valuation metric is the P/E ratio. The trailing P/E is 31.53x, while the forward P/E is 34.27x. The higher forward multiple suggests the market is pricing in expectations for near-term earnings growth, aligning with the company's recent guidance and the sector's recovery narrative. Compared to sector averages, TXN trades at a significant premium. Its trailing P/E of 31.53x and forward P/E of 34.27x are well above typical semiconductor industry averages, which often range in the low-to-mid 20s. Similarly, its Price/Sales ratio of 8.92x and EV/EBITDA of 20.59x are elevated. This premium is likely justified by the company's industry-leading margins (57% gross, 34% operating), its dominant position in the stable analog market, and its shareholder-friendly capital return policy, which offers a degree of defensive quality within the cyclical sector. Historically, the current trailing P/E of 31.53x sits above the stock's own multi-year range observed in the historical data, which has fluctuated between approximately 15x and 40x. Trading near the upper end of this historical band suggests the market is pricing in very optimistic expectations for the cyclical recovery and long-term growth in AI/data center demand. This leaves little room for error; any disappointment in execution or a slowdown in the end-market rebound could trigger a sharp multiple contraction.

PE

31.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 15x~39x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

20.6x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: TXN's primary financial risk is its elevated valuation, not its operations. The company's fundamentals are robust, with a strong balance sheet (debt-to-equity of 0.95, current ratio of 4.35) and powerful cash generation ($2.60B TTM FCF). The operational risk lies in its cyclical nature; revenue growth has just reaccelerated to 10.38% YoY after a period of decline, and any stumble in this recovery—such as a slowdown in the analog segment which drives over 95% of sales—could severely impact earnings growth expectations embedded in its high multiples. Furthermore, the slight Q4 gross margin dip to 55.89% warrants monitoring for any trend of erosion in its key profitability metric.

Market & Competitive Risks: The paramount risk is valuation compression. Trading at a forward P/E of 34.27x versus typical sector multiples in the low-to-mid 20s, TXN is priced for a flawless multi-year growth supercycle. Any macro headwind (e.g., higher-for-longer interest rates), sector-wide derating as noted in recent news, or competitive disruption could trigger a severe re-rating. The stock's beta of 1.31 confirms it is more volatile than the market, amplifying downside moves during risk-off periods. While its analog leadership provides a moat, the entire semiconductor sector faces intense competition and rapid technological change.

Worst-Case Scenario: The worst-case scenario involves a 'double-whammy' of cyclical disappointment and multiple compression. This could be triggered by a guidance cut in upcoming earnings, signaling a slower-than-expected recovery in industrial/automotive end markets, coinciding with a broader sell-off in growth stocks. In this adverse scenario, the stock could realistically retreat towards its 52-week low of $152.73, representing a downside of approximately -53% from the current price of $322.86. A more measured bear case, aligned with analyst low targets, suggests a pullback to around $378 (applying forward P/E to low EPS estimate), still a -17% decline, highlighting the asymmetric risk given the recent parabolic advance.

FAQ

The key risks, ranked by severity, are: 1) Valuation Risk: The primary risk is multiple compression from its elevated forward P/E of 34.27x if growth disappoints. 2) Cyclical Risk: As a chip stock with beta of 1.31, it is highly sensitive to economic cycles; a slowdown in industrial/auto demand could halt the recovery. 3) Execution Risk: Any stumble in maintaining its superior gross margins (currently 57%) would directly undermine the premium valuation thesis. 4) Technical Risk: The stock is up 83% in six months and trades at 95% of its 52-week range, making it prone to a sharp, sentiment-driven pullback.

The 12-month forecast presents three scenarios. The base case (50% probability) sees the stock consolidating in a range of $378 to $416, as growth meets expectations but the high valuation limits major gains. The bull case (30% probability) projects a move to $416-$464 if the supercycle accelerates and the premium multiple holds. The bear case (20% probability) warns of a correction to $300-$378 if the recovery falters. The base case is most likely, anchored by the analyst consensus target near $416, but assumes the current rich valuation will moderate as growth normalizes.

TXN is overvalued relative to its semiconductor peers and is trading near the upper end of its own historical valuation range. Its forward P/E of 34.27x and Price/Sales of 8.92x are significantly above typical sector averages. The market is paying a premium price for TXN's industry-leading margins (57% gross), dominant analog market position, and the expectation of a powerful cyclical recovery. This valuation implies the market expects near-perfect execution and sustained high-teens earnings growth, leaving the stock vulnerable to a correction if those expectations are not met.

TXN is a good stock for investors who already own it and have a long-term horizon, but it is not an ideal buy at the current price for new money. The implied 29.1% upside to the average analyst target is attractive, but the stock is trading at a stretched forward P/E of 34.27x after a 62.77% annual rally, leaving little margin for error. The biggest downside risk is a multiple compression if growth disappoints. It could be a good buy for patient investors on a significant pullback (e.g., towards $300) or for those with high conviction in an accelerating multi-year supercycle.

TXN is more suitable for a long-term investment horizon of 3-5 years rather than short-term trading. While it offers a dividend (yield ~3.2%), its value is driven by cyclical growth and capital appreciation. The stock's high beta (1.31) and position in a volatile sector make it risky for short-term traders, especially after its parabolic move. Long-term investors can benefit from the company's durable analog market leadership, strong cash flows, and shareholder returns through full market cycles. A minimum holding period of 18-24 months is suggested to navigate the anticipated volatility of the current recovery phase.